Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- DOI
- 10.1007/s40257-026-01059-6
- Published
- 2026-07-28
- Container
- American Journal of Clinical Dermatology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40257-026-01059-6,
title = {Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies},
author = {Maryanne Senna and Jennifer Soung and Ignasi Figueras and Brett King and Misaki Kinoshita-Ise and Sameh Hanna and Wenyu Wu and Dalia Wajsbrot and Deborah Woodworth and Robert Wolk and Alanna Chaudhry and Alexandre Lejeune and Helen Tran},
year = {2026},
journal = {American Journal of Clinical Dermatology},
doi = {10.1007/s40257-026-01059-6},
url = {https://doi.org/10.1007/s40257-026-01059-6}
}RIS
TY - JOUR TI - Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies AU - Maryanne Senna AU - Jennifer Soung AU - Ignasi Figueras AU - Brett King AU - Misaki Kinoshita-Ise AU - Sameh Hanna AU - Wenyu Wu AU - Dalia Wajsbrot AU - Deborah Woodworth AU - Robert Wolk AU - Alanna Chaudhry AU - Alexandre Lejeune AU - Helen Tran PY - 2026 JO - American Journal of Clinical Dermatology DO - 10.1007/s40257-026-01059-6 UR - https://doi.org/10.1007/s40257-026-01059-6 ER -
APA
Senna, M., Soung, J., Figueras, I., King, B., Kinoshita-Ise, M., Hanna, S., Wu, W., Wajsbrot, D., Woodworth, D., Wolk, R., Chaudhry, A., Lejeune, A., & Tran, H. (2026). Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies. American Journal of Clinical Dermatology. https://doi.org/10.1007/s40257-026-01059-6
Source records
- crossref · retrieved 2026-09-26T22:41:35.112Z